Centro Académico de Salud (CAS): Recent submissions
Now showing items 41-60 of 459
-
Treatment of hepatitis C virus infection with new direct-acting antivirals agents in pediatrics. Case report
(Archivos Argentinos de Pediatría, 2021-08)Abstract in English, Spanish Hepatitis C virus infection in children occurs mainly through vertical transmission. The natural history at this age consists in a high rate of spontaneous clearance, asymptomatic infection, ... -
The unfinished work of neonatal very low birthweight infants quality improvement: Improving outcomes at a continental level in South America
(Elsevier, 2021-02)Abstract Neonatal mortality rate varies between 4.2 and 18.6 per thousand by country in South America. There is little information regarding the outcomes of very low birth weight infants in the region and mortality rates ... -
The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group
(Nature Research, 2021-12)Abstract The advent of immune-checkpoint inhibitors (ICI) in modern oncology has significantly improved survival in several cancer settings. A subgroup of women with breast cancer (BC) has immunogenic infiltration of ... -
The prevalence of migraine in Argentina: A reappraisal
(SAGE Publications, 2021-06)Abstract Background: Argentina has one of the largest territories in the world, which spreads over a lengthy latitudinal span. Its population is mainly composed of a mixture of South American natives and the descendants ... -
The Latin American Association for the Study of the Liver (ALEH) position statement on the redefinition of fatty liver disease
(Elsevier, 2021-01)Abstract The Latin American Association for the Study of the Liver (Asociación Latinoamericana para el Estudio del Hígado; ALEH) represents liver professionals in Latin America with the mission of promoting liver health ... -
The impact of hydroxychloroquine on obstetric outcomes in refractory obstetric antiphospholipid syndrome
(Elsevier, 2021-10)Abstract Background: The use of low-dose aspirin (LDA) and heparin has improved pregnancy outcomes in women with antiphospholipid syndrome (APS). However, 20-30% still have adverse outcomes despite treatment. Recent ... -
The BA-BCS 2021: An Initial "Trial" for Integrating Basic Science and Medical Progress on Breast Cancer in a Latin-American Country
(Springer, 2021-09)Abstract The first Buenos Aires Breast Cancer Symposium (BA-BCS) was held in a virtual format, between the 17th and the 21st of May 2021. The main goal of the meeting was to facilitate the interaction among physicians and ... -
Targeting ADCC: A different approach to HER2 breast cancer in the immunotherapy era
(Elsevier, 2021-12)Abstract The clinical outcome of patients with human epidermal growth factor receptor 2 (HER2) amplified breast carcinoma (BC) has improved with the development of anti-HER2 targeted therapies. However, patients can ... -
SPARC inhibition accelerates NAFLD-associated hepatocellular carcinoma development by dysregulating hepatic lipid metabolism
(Wiley, 2021-07)Abstract Background and aims: Non-alcoholic fatty liver (NAFLD) and its more serious form non-alcoholic steatohepatitis increase risk of hepatocellular carcinoma (HCC). Lipid metabolic alterations and its role in HCC ... -
Simplified treatment of hepatitis C: another strategy to overcome the barriers to its elimination
(Medicina Buenos Aires, 2021-01)Abstract in English, Spanish The clinical management of hepatitis C virus (HCV) infection presents several challenges today. WHO's goal is to eliminate it by 2030. It is an ambitious goal and difficult to meet given the ... -
Severe Cutaneous Adverse Reactions to Drugs in Latin America: The RACGRAD Study
(ESMON PUBLICIDAD, 2021-07)Abstract Background and objective: Severe cutaneous adverse reactions to drugs (SCARs) are associated with high morbidity and mortality and with sequelae. Objective: To characterize patients with SCARs in 8 health care ... -
Serious liver injury induced by Nimesulide: an international collaborative study
(Springer, 2021-04)Abstract Nimesulide is a non-steroidal anti-inflammatory drug still marketed in many countries. We aim to analyze the clinical phenotype, outcome, and histological features of nimesulide-induced liver injury (nimesulide-DILI). ... -
Self-directed video versus instructor-based neonatal resuscitation training: a randomized controlled blinded non-inferiority multicenter international study
(Thieme Gruppe, 2021-07)Abstract Objective: To compare the efficacy of video-assisted self-directed neonatal resuscitation skills course with video-assisted facilitator-led course. Methods: This multicenter, randomized, blinded, non-inferio ... -
Reply
(Elsevier, 2021-03) -
Remote ischaemic conditioning in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention: an updated meta-analysis of clinical outcomes
(Taylor and Francis Group, 2021-08)Abstract Background: All previous meta-analyses including clinical outcomes after remote ischaemic conditioning (RIC) in patients with ST-elevation myocardial infarction (STEMI) treated with percutaneous coronary intervention ... -
Regorafenib Efficacy After Sorafenib in Patients With Recurrent Hepatocellular Carcinoma After Liver Transplantation: A Retrospective Study
(Wiley, 2021-12)Abstract Safety of regorafenib in hepatocellular carcinoma (HCC) recurrence after liver transplantation (LT) has been recently demonstrated. We aimed to assess the survival benefit of regorafenib compared with best ... -
Reducing medication errors for adults in hospital settings
(Cochrane Collaboration, 2021-11)Abstract Background: Medication errors are preventable events that may cause or lead to inappropriate medication use or patient harm while the medication is in the control of the healthcare professional or patient. ... -
Recurrence of hepatocellular carcinoma after liver transplantation: Prognostic and predictive factors of survival in a Latin American cohort
(Wiley, 2021-04)Abstract Background & aim: Recurrence of hepatocellular carcinoma (HCC) after liver transplantation (LT) has a poor prognosis, and the adjusted effect of different treatments on post-recurrence survival (PRS) has not been ... -
Recovering the astonishment: In palliative care, medicine, and life
(Cambridge University Press, 2021-06) -
'Real-life' experience with direct-acting antiviral agents for HCV after kidney transplant
(Elsevier, 2021-11)Abstract Introductions and objectives: The introduction of direct-acting antiviral (DAA) agents promises to change dramatically the management of hepatitis C in kidney transplant recipients, a patient group where the ...